Esta web utiliza cookies técnicas, de personalización y de análisis, propias y de terceros, para anónimamente facilitarle la navegación y analizar estadísticas del uso de la web. Obtener más información
Resultados de búsqueda
-
Equity Compensation in Startup Ventures
Nanda, Ramana; Puzio, Stephanie; White, Robert F.Caso HBS-815074-EIniciativa emprendedoraSetting equitable and "market" level compensation for founders and early employees of startups is one of the most important elements of a new venture. It is not only central to attract and retain the best human capital for the startup, but is critical to align incentives between investors and management. This note provides a framework to think about compensation in startup ventures and is intended for entrepreneurs thinking about starting a ventu...Desde 8,20 €
-
West Coast Chill, Teaching Plan
Sahlman, William A.; White, Robert F.; Puzio, StephanieNota del Instructor HBS-815139-EIniciativa emprendedoraTeaching plan for 815704.Desde 0,00 €
-
Fast Ion Battery (Spanish version)
Nanda, Ramana; Puzio, Stephanie; White, Robert F.Caso HBS-816S12Iniciativa emprendedoraA battery company is running out of money and has not met all of its milestones. The year is 2012 and many cleantech investors have decided to pull back. Fast Ion Battery needs a $5 million bridge round, but one of its three investors has refused to continue funding the company. John Davidson, a partner at Ware Street Capital and the lead investor in Fast Ion, must decide whether or not to save the company. John Davidson, a partner at Ware Street...Desde 8,20 €
-
Fast Ion Battery
Nanda, Ramana; Puzio, Stephanie; White, Robert F.Caso HBS-815025-EIniciativa emprendedoraA battery company is running out of money and has not met all of its milestones. The year is 2012 and many cleantech investors have decided to pull back. Fast Ion Battery needs a $5 million bridge round, but one of its three investors has refused to continue funding the company. John Davidson, a partner at Ware Street Capital and the lead investor in Fast Ion, must decide whether or not to save the company. John Davidson, a partner at Ware Street...Desde 8,20 €
-
The Sanofi-Aventis Acquisition of Genzyme: Contingent Value Rights
Matos, Pedro; Aleyev, Dmitriy; Xu, ChongCaso DARDEN-F-1715-EFinanzasThis case is designed for MBA students in M&A or derivatives courses. In January 2011, Sanofi-Aventis was finalizing its offer terms for acquiring Genzyme. The M&A valuation disputes were about the market potential of alemtuzumab, a drug in Genzyme’s pipeline, and how quickly Genzyme could resolve some of its manufacturing issues. To bridge the gap in their estimates, advisers had suggested an up-front cash payment and a contingent value right (C...Desde 8,20 €
-
Sanofi-Aventis's Tender Offer for Genzyme
Eades, Kenneth M.; Matos, Pedro; Aleyev, Dmitriy; Xu, ChongCaso DARDEN-F-1716-EFinanzasIn October 2010, Henri Termeer, the chairman and CEO of Genzyme, received a letter from the CEO of Sanofi-Aventis announcing its intention to commence a tender offer for Genzyme. Termeer thought the offer undervalued Genzyme, given the number of promising new drugs in the company’s pipeline and the success of its current drug portfolio. The case focuses on the strategic and financial considerations of a large corporate acquisition. To estimate Ge...Desde 8,20 €